Cannabis food oil (CBD) with 1 herb & 2 olive pastes

Some of the beneficial properties of therapeutic hemp
It can be used to treat glaucoma

May reverse the carcinogenic effects of tobacco and improve lung health
It can help treat seizures
Relieves the symptoms of arthritis
Helps in weight loss and regulates metabolism
It can treat the symptoms of Crohn’s disease
Protects brain function after a stroke
Relieves the symptoms of Parkinson’s disease
Medical use
A 2002 review of the medical literature by François Grottenharmen found that medical use of cannabis had shown positive effects in the treatment of nausea, vomiting, premenstrual syndrome, unintentional weight loss, insomnia and loss of appetite. from chemotherapy. Other relatively well-established evidence suggests the treatment of spasticity in people with multiple sclerosis, pain and in particular neurogenic pain, motor difficulties, asthma and glaucoma. [5]

Preliminary evidence suggests that cannabis-based drugs may be useful in treating adrenal dysfunction, irritable bowel syndrome, migraines, fibromyalgia and related diseases. [6] Medical cannabis use also appears to treat specific symptoms of conditions such as multiple sclerosis [7] and spinal cord injuries [8] [9], exhibiting antispasmodic and muscle relaxant effects, as well as increasing appetite in these patients.

Other medical research suggests that cannabis, or cannabinoids in particular, may be used to treat alcohol abuse [10], arthritis caused by excess collagen [11] [12], asthma [13], atherosclerosis, bipolar disorder 14], post-traumatic syndrome [15], colon cancer [16], HIV-related sensory neuropathy, dystonia [17], epilepsy [18], specific diseases of the digestive system [19], gliomas (brain tumor type) [20], hepatitis C [21], Huntington’s disease, leukemia [22], skin tumors [23], methicillin-resistant strains of Staphylococcus aureus [15] , Parkinson [24], pruritus ani, psoriasis [25], sickle cell disease [26], sleep apnea [27] and anorexia nervosa [28]. A controlled trial in the treatment of Tourette’s syndrome with a drug (Dronabinol) containing an active substance that is synthetically homologous to δ9-tetrahydrocannabinol, the main psychoactive substance in cannabis, showed that patients had a reduction in their symptoms without side effects [29 ] [30], but other research claims that it had no effect on reducing ticks [31]. Patient reports themselves show a reduction in tics with medical cannabis use [32] [33], but long-term, controlled studies are needed to demonstrate this in a larger number of patients.

Many laboratories around the world are doing intensive research to produce drugs based on cannabis ingredients, but they will not have psychotropic effects, ie they will stay away from the area of ​​the brain and will act only on the peripheral receptor to which the non-psychotropic analogues (ie the cannabinoid mimetic molecules modified by the researchers) showing high anti-inflammatory activity. The first such preparation for pain and stress was announced on July 1, 2005 in the journal Nature by researchers at the University of Georgia, and others for epilepsy and multiple sclerosis will follow.

In March 2014, the U.S. Department of Public Health approved the study on medical marijuana, marking a historic milestone in U.S. federal policy. Specifically, the Interdisciplinary Association for the Study of Psychotropic Drugs (MAPS) has been trying for the past 22 years to launch research into the development of medical cannabis-based drugs, and this is the first time since the National Marijuana was licensed for medical use. The Institute on Drug Abuse (NIDA), the only federally regulated marijuana provider in the United States.